US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 7.720
- -1.550-16.72%
Close Nov 15 16:00 ET
418.30MMarket Cap-1974P/E (TTM)
9.090High7.710Low3.15MVolume9.010Open9.270Pre Close25.85MTurnover6.38%Turnover RatioLossP/E (Static)54.18MShares15.10052wk High0.82P/B381.11MFloat Cap1.42052wk Low--Dividend TTM49.37MShs Float137.610Historical High--Div YieldTTM14.89%Amplitude1.420Historical Low8.214Avg Price1Lot Size
Emergent BioSolutions Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 7.50%283.8M | -25.11%248.1M | 85.30%292.4M | -4.93%1.02B | -16.47%269.9M | 18.65%264M | 40.74%331.3M | -47.03%157.8M | -34.36%1.08B | -49.00%323.1M |
| Operating revenue | 7.50%283.8M | -25.11%248.1M | 85.30%292.4M | -4.93%1.02B | -16.47%269.9M | 18.65%264M | 40.74%331.3M | -47.03%157.8M | -34.36%1.08B | -49.00%323.1M |
| Cost of revenue | -30.66%122.6M | 55.35%296.1M | -5.43%144.6M | 1.77%705.4M | -16.05%185.1M | 20.11%176.8M | 12.25%190.6M | -1.92%152.9M | -7.35%693.1M | 8.35%220.5M |
| Gross profit | 84.86%161.2M | -134.12%-48M | 2,916.33%147.8M | -17.08%317.6M | -17.35%84.8M | 15.80%87.2M | 114.48%140.7M | -96.55%4.9M | -57.03%383M | -76.14%102.6M |
| Operating expense | -12.96%96.7M | 1.10%128.3M | -29.18%108M | -4.98%519.1M | -14.95%128.6M | -7.88%111.1M | -7.78%126.9M | 12.46%152.5M | 7.50%546.3M | 23.83%151.2M |
| Selling and administrative expenses | -10.93%76.6M | -6.02%85.9M | -16.39%84.7M | 8.51%368.4M | -3.96%89.7M | 5.13%86M | 12.70%91.4M | 19.46%101.3M | -2.64%339.5M | -1.16%93.4M |
| Research and development costs | -9.80%13.8M | 25.77%32.7M | -62.90%15.1M | -40.84%111.4M | -37.45%29.4M | -63.74%15.3M | -47.79%26M | -12.28%40.7M | -19.94%188.3M | -44.18%47M |
| Depreciation amortization depletion | 0.00%16.3M | 1.24%16.3M | -4.71%16.2M | 9.52%65.6M | -9.50%16.2M | 16.43%16.3M | 15.00%16.1M | 21.43%17M | 2.39%59.9M | 27.86%17.9M |
| -Depreciation and amortization | 0.00%16.3M | 1.24%16.3M | -4.71%16.2M | 9.52%65.6M | -9.50%16.2M | 16.43%16.3M | 15.00%16.1M | 21.43%17M | 2.39%59.9M | 27.86%17.9M |
| Other operating expenses | -53.85%-10M | 0.00%-6.6M | -23.08%-8M | 36.47%-26.3M | 5.63%-6.7M | 62.64%-6.5M | 9.59%-6.6M | 32.29%-6.5M | 69.15%-41.4M | 89.94%-7.1M |
| Operating profit | 369.87%64.5M | -1,377.54%-176.3M | 126.96%39.8M | -23.39%-201.5M | 9.88%-43.8M | 47.24%-23.9M | 119.17%13.8M | -2,406.25%-147.6M | -142.63%-163.3M | -115.78%-48.6M |
| Net non-operating interest income expense | 57.87%-8.3M | 17.48%-23.6M | -35.75%-24.3M | -135.66%-87.9M | -69.53%-21.7M | -131.76%-19.7M | -266.67%-28.6M | -118.29%-17.9M | -8.12%-37.3M | -42.22%-12.8M |
| Non-operating interest expense | -57.87%8.3M | -17.48%23.6M | 35.75%24.3M | 135.66%87.9M | 69.53%21.7M | 131.76%19.7M | 266.67%28.6M | 118.29%17.9M | 8.12%37.3M | 42.22%12.8M |
| Other net income (expense) | 138.78%86.2M | 70.31%-69.9M | -169.39%-3.4M | -2,301.09%-441.8M | 11M | -1,558.96%-222.3M | -7,746.67%-235.4M | 345.00%4.9M | 59.47%-18.4M | 0 |
| Special income (charges) | 129.37%64.3M | 71.01%-67.2M | ---- | -6,626.87%-450.7M | --0 | ---218.9M | ---231.8M | ---- | 83.93%-6.7M | ---6.7M |
| -Less:Impairment of capital assets | --0 | -91.13%27.2M | ---- | 7,734.33%524.9M | --0 | --218.2M | --306.7M | ---- | -83.93%6.7M | --6.7M |
| -Gain on sale of business | 9,285.71%64.3M | -153.40%-40M | ---- | --74.2M | --0 | ---700K | --74.9M | ---- | --0 | --0 |
| Other non- operating income (expenses) | 744.12%21.9M | 25.00%-2.7M | -169.39%-3.4M | 176.07%8.9M | 64.18%11M | 74.63%-3.4M | -20.00%-3.6M | 345.00%4.9M | -216.22%-11.7M | 844.44%6.7M |
| Income before tax | 153.55%142.4M | -7.83%-269.8M | 107.53%12.1M | -233.88%-731.2M | 11.24%-54.5M | -295.68%-265.9M | -202.17%-250.2M | -4,126.32%-160.6M | -172.23%-219M | -123.96%-61.4M |
| Income tax | 1,204.00%27.6M | 18.75%13.3M | -87.89%3.1M | 495.95%29.3M | -189.29%-5M | -112.56%-2.5M | 142.42%11.2M | 25,700.00%25.6M | -108.84%-7.4M | -92.86%5.6M |
| Net income | 143.58%114.8M | -8.30%-283.1M | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.48%-261.4M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M |
| Net income continuous Operations | 143.58%114.8M | -8.30%-283.1M | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.48%-261.4M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 143.58%114.8M | -8.30%-283.1M | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.48%-261.4M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 143.58%114.8M | -8.30%-283.1M | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.48%-261.4M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M |
| Basic earnings per share | 142.52%2.16 | -4.26%-5.38 | 104.58%0.17 | -251.90%-14.85 | 46.02%-0.95 | -190.29%-5.08 | -356.64%-5.16 | -5,200.00%-3.71 | -202.93%-4.22 | -149.72%-1.76 |
| Diluted earnings per share | 140.55%2.06 | -4.26%-5.38 | 104.58%0.17 | -251.90%-14.85 | 46.02%-0.95 | -190.29%-5.08 | -356.64%-5.16 | -5,200.00%-3.71 | -203.94%-4.22 | -150.29%-1.76 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data
